Mar 23, 2021 / 01:38 PM EST
(CNN) The global rollout of the Oxford-AstraZeneca COVID-19 vaccine has encountered another hurdle as a handful of countries paused their use of the shot following reports it could be connected to blood clots, despite no clear evidence of a link.
AstraZeneca has robustly defended its vaccine, saying Friday there was “no evidence of an increased risk” of blood clots, and European and UK medicines regulators have each said the link between the vaccine and blood clots has not been confirmed and that rollouts should continue.
After a group of European countries including Denmark, Norway and Iceland suspended use of the vaccine on Thursday, Thailand’s Prime Minister, Prayut Chan-o-cha, canceled plans to publicly get the AstraZeneca shot on Friday and the country also delayed its rollout.
No evidence of blood clot risk from vaccine: AstraZeneca sierraleonetimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sierraleonetimes.com Daily Mail and Mail on Sunday newspapers.
Read more about No evidence of blood clot risk from Covid-19 vaccine, says AstraZeneca on Business Standard. AstraZeneca said there was no evidence of an increased risk of blood clots, and European and UK medicines regulators have each said the link between the vaccine and blood clots has not been confirmed
No evidence of blood clot risk in any age group, gender, or batch: AstraZeneca indiatvnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatvnews.com Daily Mail and Mail on Sunday newspapers.
AstraZeneca says no evidence of blood clot risk from COVID-19 vaccine india.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from india.com Daily Mail and Mail on Sunday newspapers.